George A. Samuel Iii Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

LCTX Quotes by TradingView

George A. Samuel Iii is General Counsel of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 22,184 shares of LCTX, which is worth approximately $11,535. The most recent transaction as insider was on Nov 26, 2024, when has been sold 15,000 shares (Common Shares) at a price of $0.6 per share, resulting in proceeds of $9,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.2K
208.8% 3M change
516.56% 12M change
Total Value Held $11,535

George A. Samuel III Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 26 2024
BUY
Open market or private purchase
$9,000 $0.6 p/Share
15,000 Added 40.34%
22,184 Common Shares
Feb 11 2024
SELL
Payment of exercise price or tax liability
$2,689 $1.08 p/Share
2,490 Reduced 25.74%
7,184 Common Shares, no par ...
Feb 11 2024
BUY
Exercise of conversion of derivative security
-
6,076 Added 38.58%
9,674 Common Shares, no par ...
Feb 11 2023
SELL
Payment of exercise price or tax liability
$3,345 $1.35 p/Share
2,478 Reduced 40.78%
3,598 Common Shares, no par ...
Feb 11 2023
BUY
Exercise of conversion of derivative security
-
6,076 Added 50.0%
6,076 Common Shares, no par ...
GAS

George A. Samuel Iii

General Counsel
Carlsbad, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LCTX